當前位置:首頁>學者列表>醫學院(FMD) >湯寧信>發佈文章列表[所有]
排序方式:
    總頁 40 
      Go

    1.An up-to-date review of emerging biologic therapies for hypercholesterolemia

    Tomlinson, B

    EXPERT OPINION ON BIOLOGICAL THERAPY[1471-2598], Published 2025, Volume 25, Issue 1, Pages 69-78

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  3.6 

    2.Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemia

    Tomlinson, B, Chan,     More...

    EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2025, Volume 26, Issue 3, Pages 279-289

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  2.5 

    3.Cardiomyocyte Foxp1-Specific Deletion Promotes Post-injury Heart Regeneration via Targeting Usp20-HIF1α-Hand1 Signaling Pathway

    Wang, YF, Wang, XY,     More...

    ADVANCED SCIENCE[2198-3844], Published 2025, Volume 12, Issue 12,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  14.3 

    4.Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry

    Elshorbagy, A, Valle     More...

    EUROPEAN HEART JOURNAL[0195-668X], Published 2025, Volume 46, Issue 12, Pages 1127-1140

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  38.1 

    5.Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors

    Tomlinson, Brian, Wu     More...

    Journal of Lipid and Atherosclerosis[2287-2892], Published 2024, Volume 13, Issue 1, Pages 2-20

    收錄情况: SCOPUS

    6.Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank

    Jin, Q, Lau, ESH, Lu     More...

    DIABETOLOGIA[0012-186X], Published 2024, Volume 67, Issue 5, Pages 837-849

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  8.4 

    7.Genetic drivers of heterogeneity in type 2 diabetes pathophysiology

    Suzuki, K, Hatzikoto     More...

    NATURE[0028-0836], Published 2024, Volume 627, Issue 8003, Pages 347-357

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 105  2023影響因子:  50.5 

    8.Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update

    Tomlinson, B, Chan,     More...

    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2024, Volume 20, Issue 4, Pages 175-179

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  3.9 

    9.The maximum dose of atorvastatin and simvastatin as well as rosuvastatin should be restricted in East Asians

    Tomlinson, B, Chow,     More...

    HONG KONG MEDICAL JOURNAL[1024-2708], Published 2024, Volume 30, Issue 2, Pages 184-185

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  3.1 

    10.Genetic factors related to aspirin resistance using the Multiplate® device in Hong Kong Chinese patients with stable coronary heart disease

    Zeng, WW, Chu, TTW,     More...

    HELIYON[2405-8440], Published 2024, Volume 10, Issue 14,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  3.4 

    11.Therapeutic efficacy of ECs Foxp1 targeting Hif1α-Hk2 α-Hk2 glycolysis signal to restrict angiogenesis

    Pi, JJ, Chang, H, Ch     More...

    REDOX BIOLOGY[2213-2317], Published 2024, Volume 75,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  10.7 

    12.Options for patients with out-of-control blood pressure: after all avenues have been exhausted

    Zeng, WW, Tomlinson,     More...

    EXPERT REVIEW OF CARDIOVASCULAR THERAPY[1477-9072], Published 2024,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  1.8 

    13.Effects of Hawthorn Fruit Extract Drink in Chinese Patients With Mild Hypertension and/or Hyperlipidaemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

    Zeng, WW, Chu, TTW,     More...

    DOSE-RESPONSE[1559-3258], Published 2024, Volume 22, Issue 4,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  2.3 

    14.Statin alternatives for the treatment of hypercholesterolemia - a safety evaluation

    Zeng, WW, Tomlinson,     More...

    EXPERT OPINION ON DRUG SAFETY[1474-0338], Published 2024,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  3.0 

    15.Advances in statin adverse reactions and the potential mechanisms: A systematic review

    Zeng, Weiwei, Deng,     More...

    Journal of Advanced Research[2090-1232], Published 2024,

    收錄情况: SCOPUS

    2023影響因子:  11.4 

    16.Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

    Elshorbagy, A, Lyons     More...

    LANCET DIABETES & ENDOCRINOLOGY[2213-8587], Published 2024, Volume 12, Issue 11, Pages 811-823

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  44.0 

    17.Pharmacogenomics: The roles of genetic factors on treatment response and outcomes in diabetes

    Wang, Ke, Chow, Elai     More...

    Internet of Things and Machine Learning for Type I and Type II Diabetes: Use Cases, Published 2024, Pages 367-395

    收錄情况: SCOPUS

    18.Editorial

    Brian Tomlinson

    The Hong Kong Medical Diary: Clinical Pharmacology[1812-1691], Published 2024, Volume 29, Issue 12, Pages 2

    19.Management of Resistant Hypertension

    Brian TOMLINSON, Iat     More...

    The Hong Kong Medical Diary: Clinical Pharmacology[1812-1691], Published 2024, Volume 29, Issue 12, Pages 4-7

    20.Hypertension Management - the Role of Beta-blockers

    Yu-tak HUNG, Brian T     More...

    The Hong Kong Medical Diary: Clinical Pharmacology[1812-1691], Published 2024, Volume 29, Issue 12, Pages 13, 16

    顯示      條  合計  783  條
      總頁 40 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫